Literature DB >> 25301398

Effects of antioxidant gene therapy on the development of diabetic retinopathy and the metabolic memory phenomenon.

Liwei Zhang1, Huiming Xia, Qianqian Han, Baihua Chen.   

Abstract

PURPOSE: The purpose of this study was to determine the therapeutic effect and mechanism of AAV-MnSOD by intravitreal injection on diabetic retinopathy (DRP) and the metabolic memory phenomenon.
METHODS: The effect of hyperglycemia and metabolic memory on the thickness of basement membrane, ratio of pericyte area and cross-sectional area of capillary vessels in the nerve fiber layer and outer plexiform layer; retinal capillary cell apoptosis; number of acellular capillaries and activities of retinal MnSOD and catalase were examined and compared with intravitreal injection of AAV-MnSOD by transmission electron microscopy, TUNEL assay, ELISA, and immunohistochemistry.
RESULTS: Hyperglycemia increased the thickness of capillary basement membranes in the nerve fiber layer and outer plexiform layer, decreased the ratio of pericyte area and cross-sectional area of capillary vessels, increased numbers of acellular capillaries and apoptosis of retinal capillary cells, and decreased activities of retinal MnSOD and catalase. Termination of hyperglycemia cannot reverse pathological changes listed above. Intra-vitreal injection of AAV-MnSOD dramatically elevated the level and activities of retinal MnSOD and catalase, and effectively prevented the progression of DRP and the metabolic memory phenomenon.
CONCLUSIONS: Increasing reactive oxygen species concentration and continuous decreasing of antioxidant enzyme activity play important roles in DRP and the metabolic memory phenomenon. AAV-MnSOD gene therapy provides a promising strategy to inhibit this blinding disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25301398     DOI: 10.1007/s00417-014-2827-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  63 in total

1.  Production and purification of recombinant adeno-associated virus.

Authors:  W W Hauswirth; A S Lewin; S Zolotukhin; N Muzyczka
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes.

Authors:  Renu A Kowluru; Qing Zhong; Mamta Kanwar
Journal:  Exp Eye Res       Date:  2010-02-17       Impact factor: 3.467

3.  Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress.

Authors:  Renu A Kowluru; Vibhuti Kowluru; Ye Xiong; Ye-Shih Ho
Journal:  Free Radic Biol Med       Date:  2006-02-06       Impact factor: 7.376

4.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.

Authors:  Renu A Kowluru; Sarah Odenbach
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

6.  Pigment-epithelium-derived factor down regulates hyperglycemia-induced apoptosis via PI3K/Akt activation in goat retinal pericytes.

Authors:  Ravinarayanan Haribalaganesh; Sardarpasha Sheikpranbabu; Banumathi Elayappan; Deepak Venkataraman; Sangiliyandi Gurunathan
Journal:  Angiogenesis       Date:  2009-11-12       Impact factor: 9.596

7.  Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature.

Authors:  Baihua Chen; Sergio Caballero; Soojung Seo; Maria B Grant; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

8.  Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs.

Authors:  Lin Xie; Xiaobo Zhu; Yiqun Hu; Tao Li; Yi Gao; Yu Shi; Shibo Tang
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

9.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

Authors:  Neil H White; Wanjie Sun; Patricia A Cleary; Ronald P Danis; Matthew D Davis; Dean P Hainsworth; Larry D Hubbard; John M Lachin; David M Nathan
Journal:  Arch Ophthalmol       Date:  2008-12

10.  Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.

Authors:  M A Ihnat; J E Thorpe; C D Kamat; C Szabó; D E Green; L A Warnke; Z Lacza; A Cselenyák; K Ross; S Shakir; L Piconi; R C Kaltreider; A Ceriello
Journal:  Diabetologia       Date:  2007-05-17       Impact factor: 10.122

View more
  10 in total

1.  Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes.

Authors:  Karin Dreisig; Frank Wojciechowski Blixt; Karin Warfvinge
Journal:  J Vis Exp       Date:  2018-10-07       Impact factor: 1.355

2.  Association of bilirubin and malondialdehyde levels with retinopathy in type 2 diabetes mellitus.

Authors:  Apoorva Dave; Pramila Kalra; B H Rakshitha Gowda; Malavika Krishnaswamy
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

3.  Diabetes Onset at 31-45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes.

Authors:  Wenjun Zou; Lisha Ni; Qianyi Lu; Chen Zou; Minjie Zhao; Xun Xu; Haibing Chen; Zhi Zheng
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

4.  Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2017-03-14

5.  Integrated bioinformatic changes and analysis of retina with time in diabetic rats.

Authors:  Zekai Cui; Qiaolang Zeng; Yonglong Guo; Shiwei Liu; Jiansu Chen
Journal:  PeerJ       Date:  2018-05-16       Impact factor: 2.984

Review 6.  Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies.

Authors:  Michael Whitehead; Sanjeewa Wickremasinghe; Andrew Osborne; Peter Van Wijngaarden; Keith R Martin
Journal:  Expert Opin Biol Ther       Date:  2018-11-14       Impact factor: 4.388

7.  Astragalus polysaccharides suppresses high glucose-induced metabolic memory in retinal pigment epithelial cells through inhibiting mitochondrial dysfunction-induced apoptosis by regulating miR-195.

Authors:  Ping Liu; Qing-Hua Peng; Ping Tong; Wen-Jie Li
Journal:  Mol Med       Date:  2019-05-22       Impact factor: 6.354

Review 8.  Experiment-Based Interventions to Diabetic Retinopathy: Present and Advances.

Authors:  Siwei Liu; Yahan Ju; Ping Gu
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 9.  Updates on Gene Therapy for Diabetic Retinopathy.

Authors:  Jiang-Hui Wang; Georgina Eloise Roberts; Guei-Sheung Liu
Journal:  Curr Diab Rep       Date:  2020-05-16       Impact factor: 4.810

10.  DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice.

Authors:  Ying Zhu; Xinru Wang; Xiaoyun Zhou; Lexi Ding; Dan Liu; Huizhuo Xu
Journal:  Biol Res       Date:  2021-08-06       Impact factor: 5.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.